Skip to main content
. 2021 Aug 2;22(4):1103. doi: 10.3892/etm.2021.10537

Figure 2.

Figure 2

Dizziness Handicap Inventory of female patients with Meniere's disease treated with 2 mg drospirenone and 1 mg 17β-estradiol hormone therapy for 3 and 6 months combined with rehabilitation (group A), or rehabilitation alone (group B). *P<0.001; **P<0.01 vs. baseline.